Quality Inspection for Paclitaxel And Carboplatin Cost - Puerarin 10-98% CAS 3681-99-0 pharmaceutical raw materials – Hande Detail:
Product Informations
1、 Introduction to puerarin
Puerarin, also known as puerarin flavone, is a natural isoflavone carboglycoside, which is the key component of puerarin to exert its efficacy. Puerarin has the functions of lowering blood glucose, regulating blood lipid, protecting blood vessels, anti oxidative stress, anti infection, improving insulin sensitivity index, etc., and has less adverse reactions. It is known as “phytoestrogen”, and is clinically used to treat cardiovascular and cerebrovascular diseases, cancer, Parkinson’s disease, Alzheimer’s disease, diabetes and diabetes complications.
2、 Effect of Puerarin
Puerarin was injected into the coronary artery of anesthetized dogs, which showed that it could increase cerebral blood flow and reduce vascular resistance. Puerarin can also protect myocardial ischemia caused by neurohypophysin. Both in vivo and in vitro experiments show that puerarin can produce competitive effects on rabbit arterial smooth muscle and airway smooth muscle β- Receptor antagonism. Puerarin can reduce the blood pressure and heart rate of spontaneously hypertensive rats, but it has little effect on normal Wistar rats. Puerarin can inhibit the anti tetrodotoxin Na current of central neurons of rat spinal nerve roots (tetrodotoxin is a sodium channel specific blocker, which can block the inward Na current), has the neuroprotective effect of anti cerebral ischemia, and improves cerebral blood flow by expanding intracranial arteries. This effect is dose-dependent. Puerarin can also reduce blood pressure, especially renal hypertension.
3、 Application fields of Puerarin
Medicine, health food
Product Parameters
COMPANY PROFILE | |
Product Name | Puerarin |
CAS | 3681-99-0 |
Chemical Formula | C21H20O9 |
Brand | Hande |
Manufacturer | Yunnan Hande Bio-Tech Co., Ltd. |
Country | Kunming, China |
Established | 1993 |
BASIC INFORMATION | |
Synonyms | PUERARIN;Puerain;8-(β-D-Glucopyranosyl)-4′,7-dihydroxyisoflavone;Pueraria flavonoids;Puerarin std.; Daidzeinum; Tapocon;Puerqarin;Kakonein;;daidzein-8-C-glucose;Purerarin;Puerarine; |
Structure | |
Weight |
|
HS Code | N/A |
Quality Specification | Company Specification |
Certificates | N/A |
Assay | Customized according to customer needs |
Appearance | White to yellowish crystalline powder |
Method of Extraction | Pueraria lobata (Willd.)Ohwi |
Annual Capability | Customized according to customer needs |
Package | Customized according to customer needs |
Test Method | HPLC |
Logistics | Multiple transports |
Payment Terms | T/T, D/P, D/A |
Other | Accept customer audit all the time; Assist clients with regulatory registration. |
Hande product statement
1.All products sold by the company are semi-finished raw materials. The products are mainly aimed at manufacturers with production qualifications, and raw materials are not final products.
2.The potential efficacy and applications involved in the introduction are all from the published literature. Individuals do not recommend direct use, and individual purchases are refused.
3.The pictures and product information on this website are for reference only, and the actual product shall prevail.
Product detail pictures:
Related Product Guide:
We enjoy a very good reputation among our customers for our excellent product quality, competitive price and the best service for Quality Inspection for Paclitaxel And Carboplatin Cost - Puerarin 10-98% CAS 3681-99-0 pharmaceutical raw materials – Hande, The product will supply to all over the world, such as: California, New Delhi, Orlando, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world
By Vanessa from Saudi Arabia - 2018.05.13 17:00
We have worked with many companies, but this time is the best,detailed explanation, timely delivery and quality qualified, nice!
By May from Lahore - 2017.12.02 14:11